Financial Year |
March 31 2023 |
Monetary Funds |
613,676,503.44 |
Held-for-trading Financial Assets |
271,616,825.40 |
Notes Receivable |
-- |
Accounts Receivable |
351,008,774.54 |
Advances to Suppliers |
1,766,238.34 |
Other Receivables |
12,675,754.08 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
2,991,780.72 |
Dividend Receivable |
-- |
Inventories |
350,824,017.39 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
7,982,178.29 |
Total Current Assets |
1,609,550,291.48 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
3,250,220.10 |
Investment Properties |
34,021,024.54 |
Fixed Assetes |
313,015,836.64 |
Under-construction Projects |
1,817,787.59 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
16,983,655.73 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
2,848,406.66 |
Deferred Income Tax Assets |
117,194,135.37 |
Other Non-Current Assets |
15,018,896.85 |
Sub-Total of Non-Current Assets |
504,792,428.44 |
Total Assets |
2,114,342,719.92 |
Short-Term Loans |
38,910,187.76 |
Trading Financial liabilities |
-- |
Notes Payable |
26,454,440.92 |
Accounts Payable |
193,044,302.52 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
13,046,379.91 |
Taxes Payable |
339,040.10 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
7,091,964.66 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
324,912.83 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
376,599,048.19 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
171,774,556.87 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
103,255,181.28 |
Sub-Total of Non-Current Liabilities |
293,786,493.06 |
Total Liabilities |
670,385,541.25 |
Paid-In Capital(Or Share Stock) |
520,520,000.00 |
Capital Surplus |
755,885,846.82 |
Surplus Reserve |
46,294,313.56 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
121,257,018.29 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,443,957,178.67 |
Owner's Equity(Stockholder's Equity) |
1,443,957,178.67 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,114,342,719.92 |